India Generic Injectables Market to Reach US$ 7.0 Billion by 2032, Augmented by the Growing Prevalence of Chronic Diseases

July 27, 2022 | Healthcare

The latest report by IMARC Group, titled “India Generic Injectables Market Report by Therapeutic Area (Oncology, Anaesthesia, Anti-infectives, Parenteral Nutrition, Cardiovascular), Container (Vials, Ampoules, Premix, Prefilled Syringes), Distribution Channel (Hospitals, Retail Pharmacy), and Region 2024-2032,” finds that the India generic injectables market size reached US$ 2.7 Billion in 2023. A generic injectable is a drug having the same pharmaceutical composition as its branded counterpart in safety, strength, dosage form, performance, quality, and route of administration. It is cost-effective as generic injectable does not have to undergo animal testing and clinical studies to demonstrate safety and effectiveness. As it also delivers the same amount of active ingredients to the body, the demand for generic injectables is rising across India.

India Generic Injectables Market Trends:

The growing prevalence of chronic diseases, such as cancer, stroke, diabetes, septicemia, influenza and pneumonia, and respiratory and Alzheimer's disease, represents one of the key factors driving the market in India. Moreover, the Government of India is extensively investing in research and development (R&D) activities to support the introduction of innovative generic injectables and provide effective drug administration, thereby enabling faster recovery of patients. This, along with the expanding healthcare industry, is contributing to the growth of the market in the country. In addition, technological advancements in the drug delivery systems, such as the introduction of self-injection devices, are positively influencing the market. Besides this, the increasing number of health insurance companies in the country is offering lucrative growth opportunities to industry investors. Additionally, the rising awareness among the masses about the benefits of using generic injectables is propelling the growth of the market in India. Apart from this, there is a rise in the shortage of branded medicines and the expiry of patents of branded items in the country. This, coupled with the burgeoning life science industry, is catalyzing the demand for generic injectables. Furthermore, the introduction of 3D printing technology in the country that helps manufacture generic drugs with varying release dates and tastes is bolstering the growth of the market. Looking forward, IMARC Group expects the market to reach US$ 7.0 Billion by 2032, exhibiting a CAGR of 10.8% during the forecast period (2024-2032).

Market Summary:

  • Based on the therapeutic area, the market has been classified into oncology, anesthesia, anti-infectives, parenteral nutrition, and cardiovascular. At present, oncology exhibits a clear dominance in the market.
  • On the basis of the container, the market has been segmented into vials, ampoules, premix, and prefilled syringes. Presently, vials hold the largest share of the market.
  • Based on the distribution channel, the market has been bifurcated into hospitals and retail pharmacies. Amongst these, hospitals account for the majority of the total market share.
  • Region-wise, the market has been segregated into North, South, East and West and Central India. North India dominates the market and holds the biggest share of the market.
  • The competitive landscape of the market has been studied in the report.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Therapeutic Area, Container, Distribution Channel, Region
Region Covered  North India, West and Central India, South India, East India
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
India Generic Injectables Market to Reach US$ 7.0 Billion by 2032, Augmented by the Growing Prevalence of Chronic Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More